Vol 2, No 2 (2010)
Mol Cell Pharmacol
Table of Contents
PharmSights
| Hsp70 ATPase Modulators as Therapeutics for Alzheimer’s and other Neurodegenerative Diseases | Abstract PDF |
| Umesh K. Jinwal, John Koren III, John C. O’Leary III, Jeffrey R. Jones, Jose F. Abisambra, Chad A. Dickey | 43-46 |
| Potency of Claudin-targeting as Antitumor Therapy | Abstract PDF |
| Rie Saeki, Masuo Kondoh, Hiroshi Uchida, Kiyohito Yagi | 47-51 |
| Lansoprazole, a Proton Pump Inhibitor, to Reduce Gastrointestinal Inflammation via Heme Oxygenase-1 Induction | Abstract PDF |
| Yuji Naito, Tomohisa Takagi, Toshikazu Yoshikawa | 53-60 |
Research Articles
| Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family | Abstract PDF |
| Qin He, Jingxue Shi, Hong Sun, Jie An, Ying Huang, M. Saeed Sheikh | 61-68 |
Reviews
| Decision Making by p53: Life versus Death | Abstract PDF |
| Lingyan Jiang, M. Saeed Sheikh, Ying Huang | 69-77 |
FDA Corner
| FDA Approves New Use of Xifaxan for Patients with Liver Disease | Abstract PDF |
| 79 |
| FDA Approves Therapy to Treat Gaucher Disease | Abstract PDF |
| 79 |
| FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia | Abstract PDF |
| 80 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.